Related Experiment Videos
Ongoing clinical trials of statins.
1Weill Medical College of Cornell University, New York, New York 10021, USA. amg_editorial@med.cornell.edu
The American Journal of Cardiology
|August 25, 2001
Summary
Statins effectively prevent coronary artery disease in patients with high or normal cholesterol. Ongoing trials explore statin use in elderly, diabetic, and female populations, and assess benefits of lower lipid goals.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Lipid-lowering treatment, particularly with statins, is crucial for preventing coronary artery disease (CAD).
- Statins are established for primary and secondary prevention in patients with hypercholesterolemia and average cholesterol levels.
Purpose of the Study:
- To evaluate ongoing and planned clinical trials on statin therapy.
- To investigate the role of statins in diverse patient cohorts, including the elderly, diabetics, and women.
- To assess the impact of more aggressive lipid-lowering strategies and early statin initiation.
Main Methods:
- Review of ongoing and planned clinical endpoint trials.
- Analysis of trial designs focusing on specific populations (elderly, diabetic, women).
- Evaluation of studies testing lipid reduction below current goals and early aggressive treatment.
Main Results:
- Current trials are expanding the understanding of statin efficacy in broader populations.
- Emerging data will clarify benefits of intensive lipid lowering and early intervention.
- These studies will refine guidelines for statin use in cardiovascular disease prevention.
Conclusions:
- Statins remain a cornerstone in managing coronary artery disease risk.
- Future research will define optimal lipid targets and treatment strategies for diverse patient groups.
- Evidence is accumulating to support broader and potentially more aggressive use of statins.